Woman Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
To evaluate the Overall Response Rate (ORR) of oral vinorelbine (Navelbine Oral) in combination with capecitabine (Xeloda) for HER2 negative patients.
Inclusion criteria
- Treatment in women with previously untreated HER2 negative metastatic breast cancer